Pioglitazone HCL and Metformin HCL 850 mg/1

Pioglitazone HCL and Metformin HCL 850 mg/1 tablets combine two active ingredients for managing blood sugar levels. This oral medication is commonly used in diabetes care to improve insulin sensitivity and reduce glucose production in the liver.

Pioglitazone HCL and Metformin HCL 850 mg/1 tablets are typically used to manage type 2 diabetes. Pioglitazone works by making your body more sensitive to insulin, while Metformin helps lower glucose production in the liver. Together, they help control blood sugar levels. This combination is often prescribed when diet and exercise alone are not enough to manage diabetes effectively.

Common effects of Pioglitazone HCL and Metformin HCL 850 mg/1 tablets may include weight gain, headaches, and digestive issues like nausea or diarrhea. Some users may also experience fluid retention or mild dizziness. These effects vary and are not experienced by everyone.

Handle Pioglitazone HCL and Metformin HCL 850 mg/1 tablets with care, especially if you have a history of liver or kidney issues. Always follow the advice of your healthcare provider regarding usage and monitor your blood sugar levels regularly. Avoid alcohol while taking this medication.

Pioglitazone HCL and Metformin HCL 850 mg/1 tablets may interact with certain medications, including other diabetes drugs, steroids, and some antibiotics. Always inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol can also affect how this medication works.